Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
Chapman, Arlene B
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Jul 2008 - 1197-204 p. digital
Publication Type: Journal Article; Review
1555-905X
10.2215/CJN.00060108 doi
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Antihypertensive Agents--pharmacology
Blood Pressure--drug effects
Clinical Trials as Topic
Disease Progression
Humans
Kidney--drug effects
Magnetic Resonance Imaging
Polycystic Kidney, Autosomal Dominant--drug therapy
Renin-Angiotensin System--drug effects
Treatment Outcome
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. [electronic resource] - Clinical journal of the American Society of Nephrology : CJASN Jul 2008 - 1197-204 p. digital
Publication Type: Journal Article; Review
1555-905X
10.2215/CJN.00060108 doi
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Antihypertensive Agents--pharmacology
Blood Pressure--drug effects
Clinical Trials as Topic
Disease Progression
Humans
Kidney--drug effects
Magnetic Resonance Imaging
Polycystic Kidney, Autosomal Dominant--drug therapy
Renin-Angiotensin System--drug effects
Treatment Outcome